Jan 31, 2023Drug Discovery & DevelopmentYmmunobio get ownership rights to NPTXR antibodies. Read more here:https://www.drugdiscoverytrends.com/ymmunobio-gets-ownership-rights-to-nptxr-antibodies/
Ymmunobio get ownership rights to NPTXR antibodies. Read more here:https://www.drugdiscoverytrends.com/ymmunobio-gets-ownership-rights-to-nptxr-antibodies/
Jan 13, 2023Fierce Biotech: Appointment of Michel JanicotMichel Janicot will serve in the newly created position of chief development officer.https://www.fiercebiotech.com/biotech/chutes-ladders-novavax-ceo-erck-bids-adieu-after-12-years-overseeing-covid-vax-development
Michel Janicot will serve in the newly created position of chief development officer.https://www.fiercebiotech.com/biotech/chutes-ladders-novavax-ceo-erck-bids-adieu-after-12-years-overseeing-covid-vax-development
Jan 10, 2023Ymmunobio Appoints Dr. Michel Janicot as Chief Development OfficerYmmunobio adds to executive team.Read more here: https://www.biopharmadive.com/press-release/20230109-ymmunobio-appoints-dr-michel-janicot-as-chief-development-officer/
Ymmunobio adds to executive team.Read more here: https://www.biopharmadive.com/press-release/20230109-ymmunobio-appoints-dr-michel-janicot-as-chief-development-officer/
